This last week of October – a Breast Cancer Awareness Month – is a good time to share Hokkaido University’s important news:
A compound effective in killing chemotherapy-resistant glioblastoma-initiating cells (GICs) has been identified, raising hopes of producing drugs capable of eradicating refractory tumors with low toxicity. https://www.sciencedaily.com/releases/2019/10/191018091238.htm